This innovative peptide solution is designed to competitively block adhesion of Fusobacterium nucleatum to the oral mucosa, preventing gum disease. It utilizes PRB3-derived peptides to interfere with bacterial binding, offering a novel approach for oral healthcare products.
This peptide solution offers a groundbreaking approach to enhancing oral health by preventing the adhesion of Fusobacterium nucleatum, a bacterium linked to gum disease. By leveraging peptides derived from the PRB3 protein, this solution competes with bacterial binding sites, reducing microbial adhesion and potentially decreasing oral infections. This innovation holds promise for integration into oral healthcare products to maintain a healthier oral microbiome.
Key features:
The peptide's design is based on well-established interactions of PRB3 with bacterial proteins, ensuring effective competition against microbial adhesion. The strategy has parallels in successful therapeutic developments, particularly in antimicrobial applications.
Currently at TRL 3, this peptide technology is in the early stages of development, with in vitro efficacy studies planned to test its ability to block Fusobacterium nucleatum adhesion. Toxicity assessments and further validation studies, including AI-driven chemical screenings, are also part of the development roadmap.
Xi’an Jiaotong‑Liverpool University is a Sino‑British joint university in Suzhou, operating as a research‑led, internationally oriented institution. Its main campus in the Suzhou Dushu Lake Science and Education Innovation District of Suzhou Industrial Park gives companies access to a dense innovation ecosystem and nearby advanced manufacturing. The Entrepreneur College in Taicang runs industry‑themed schools and an embedded co‑education model that aligns talent pipelines and applied R&D with partner firms in a nearby high‑tech zone. Research is supported by competitive national, provincial and municipal programs in China, including awards from the National Natural Science Foundation of China. A dedicated Research Engagement and Innovation Office enables collaboration, technology transfer and IP management.